Galectin Therapeutics Inc (GALT)

0.8699 +0.03 (+3.49%) USD  |  NASDAQ  |  Dec 26, 12:42
More

Galectin Therapeutics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Alaunos Therapeutics Inc Upgrade
SELLAS Life Sciences Group Inc Upgrade
Oragenics Inc Upgrade
Anavex Life Sciences Corp Upgrade
Phathom Pharmaceuticals Inc Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade